Broker Recommendations
Berenberg downgrades Softcat after share price strength
Berenberg downgraded its recommendation on shares of IT infrastructure provider Softcat to ‘hold’ from ‘buy’ on Monday following a recent run higher in the share price that has left the stock trading at a 45% premium to its long-term historical levels and a "significant" premium to global peers.
Canaccord Genuity ups Bovis Homes to 'buy'
Canaccord Genuity upped its stance on shares of housebuilder Bovis Homes to ‘buy’ from ‘hold’ on Friday, lifting the price target to 1,260p from 1,150p as it highlighted the "good strategic rationale" of its acquisition of Galliford Try’s housing business.
Buy Coats Group shares on weakness, says RBC Capital Markets
Shares of industrial thread maker Coats Group slumped on Friday as it said that sales in the four months to the end of October slowed.
Berenberg raises target price on Frontier Developments
Analysts at Berenberg raised their target price on shares of British video games group Frontier Developments to 1,600p from 1,350p on Friday, saying the company appears to be nearing an inflection point.
Canaccord raises target price on Mitchells & Butlers
Analysts at Canaccord Genuity raised their target price on pub landlord Mitchells & Butlers from 400p to 530p on Thursday, stating better than expected preliminary results showed the firm was continuing to outperform the market.
Berenberg labels Domino's recent share price rise 'overdone'
Analysts at Berenberg slightly raised their target price on 'sell' rated restaurant chain Domino's Pizza Group on Thursday, stating that the stock's rise in recent months was "overdone".
Thursday broker round-up
Fevertree: Deutsche Bank downgrades to hold with a target price of 2,200p.
Berenberg slashes target price on Burford Capital, downgrades to 'hold'
Analysts at Berenberg absolutely slashed their price target on finance firm Burford Capital from 2,070p to 810p on Wednesday following a "tough six months" for the group.
Wednesday broker round-up
Burford Capital: Berenberg downgrades to hold with a target price of 810p.
Barclays slashes target price for Equiniti as margins and cash flow disappoint
Analysts at Barclays cut their target price for Equiniti's shares on the heels of weaker UK macroeconomic conditions that hit its Pensions arm in the second half of the year, falling interest rates in the States and the drag from foreign exchange rates.
Canaccord raises target price for EasyJet substantially, but stays at 'hold'
Analysts at Canaccord Genuity revised their target price for easyJet substantially higher to reflect the company's modest fleet expansion in the coming years and, at least in the near-term, heightened industry-wide discipline when it comes to adding capacity.
Canaccord Genuity sees 'attractive' shareholder value in Forterra and Ibstock
Cannacord Genuity initiated coverage of shares in Forterra and Ibstock with 'buy' and 'hold' recommendations, respectively, telling clients their expectation was for both companies to "deliver attractive profitability and returns for the foreseeable future".
Morgan Stanley shows preference for Lloyds among UK listed lenders
Analysts at Morgan Stanley upgraded their view on European lenders' shares, including for the various London-listed banks, from 'in-line' to 'attractive'.
Berenberg ups target price on Jadestone Energy
Analysts at Berenberg upped their target price on upstream oil and gas firm Jadestone Energy on Tuesday following the group's acquisition of a 69% working interest in the Maari project in the Taranaki Basin, offshore New Zealand.
Monday broker round-up
Croda International: Liberum Capital downgrades to hold with a target price of 4,400p.
Berenberg hails Vodafone's move towards Open RAN technology
Analysts at Berenberg reiterated their 'buy' recommendation for shares of Vodafone following the company's announcement that it was studying a possible redesign of all its European cell sites based on so-called Open RAN technology which the analysts said could yield multiple benefits, including sharply reduced operating and capital expenditure costs.
Jefferies upgrades HSBC to 'buy' on restructuring plans
Analysts at Jefferies upgraded their recommendation for shares of HSBC from 'hold' to 'buy' in anticipation of an uplift to the lender's return on capital as it restructured some of its operations.
ShoreCap downgrades Consort Medical to 'hold' after all-cash offer from Recipharm
Analysts at ShoreCap downgraded their recommendation for shares of Consort Medical from 'buy' to 'hold' following the recommended cash offer from Recipharm.